Literature DB >> 1701066

Epididymal metastasis from prostatic adenocarcinoma mimicking adenomatoid tumor.

C C Rizk1, J Scholes, S K Chen, J Ward, N A Romas.   

Abstract

A case of epididymal metastasis from prostatic carcinoma is presented. The initial histologic findings were suggestive of adenomatoid tumor, but a diagnosis of metastatic adenocarcinoma of prostatic origin has been established by prostatic acid phosphatase and prostate-specific antigen immunoperoxidase staining.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701066     DOI: 10.1016/0090-4295(90)80194-r

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

Review 1.  [Testicular metastasis of a metachronous small cell neuroendocrinic prostate cancer after anti-hormonal therapy of a prostatic adenocarcinoma. Case report and literature review].

Authors:  A Schneider; A Kollias; J Woziwodzki; G Stauch
Journal:  Urologe A       Date:  2006-01       Impact factor: 0.639

2.  Epididymal metastasis from prostate adenocarcinoma: An unusual and challenging diagnosis suspected in gallium-68 prostate-specific membrane antigen-positron emission tomography/computed tomography and histologically confirmed.

Authors:  Sofia Santos-Lopes; João Lobo; Rui Henrique; Jorge Oliveira
Journal:  Urol Ann       Date:  2017 Jan-Mar

3.  High level of endostatin in epididymal epithelium: protection against primary malignancies in this organ?

Authors:  Derya Tilki; Nerbil Kilic; Hermann Herbst; Oliver Reich; Michael Seitz; Heidrun Lauke; Christian G Stief; Süleyman Ergün
Journal:  Histochem Cell Biol       Date:  2008-05-14       Impact factor: 4.304

Review 4.  Clinicopathological Characteristics, Treatment, and Prognosis of Rarely Primary Epididymal Adenocarcinoma: A Review and Update.

Authors:  Zi-Jun Zou; Ying-Ming Xiao; Zhi-Hong Liu; Ruo-Chen Zhang; Jia-Yu Liang; Yong-Quan Tang; Yi-Ping Lu
Journal:  Biomed Res Int       Date:  2017-12-20       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.